ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 662,30
-0,58%
Dow Jones
39 112,16
-0,76%
DAX
18 177,62
-0,90%
Brent Oil
84,455
0,32%
Bitcoin
62 184,21
0,62%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Twist Bioscience Corporation (TWST)

  7. Twist Bioscience Corporation (TWST) Actualités

TWST

Twist Bioscience (TWST)

Twist Bioscience Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TWST
DateHeureSourceTitreSymboleSociété
18/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
14/06/202421h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
06/06/202414h00Business WireTwist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint InhibitorNASDAQ:TWSTTwist Bioscience Corporation
04/06/202414h00Business WireTwist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI SafetyNASDAQ:TWSTTwist Bioscience Corporation
23/05/202414h00Business WireTwist Bioscience to Present at Upcoming Investor ConferencesNASDAQ:TWSTTwist Bioscience Corporation
13/05/202414h00Business WireTwist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening ApplicationsNASDAQ:TWSTTwist Bioscience Corporation
08/05/202414h00Business WireTwist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
02/05/202422h05Business WireTwist Bioscience Reports Fiscal Second Quarter 2024 Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
18/04/202414h00Business WireTwist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024NASDAQ:TWSTTwist Bioscience Corporation
28/03/202413h00Business WireTwist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse PopulationsNASDAQ:TWSTTwist Bioscience Corporation
05/03/202414h00Business WireTwist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome SequencingNASDAQ:TWSTTwist Bioscience Corporation
12/02/202423h42Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TWSTTwist Bioscience Corporation
07/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TWSTTwist Bioscience Corporation
07/02/202414h00Business WireTwist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
06/02/202414h05Business WireTwist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI SystemNASDAQ:TWSTTwist Bioscience Corporation
06/02/202414h00Business WireTwist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy ApplicationsNASDAQ:TWSTTwist Bioscience Corporation
05/02/202414h00Business WireTwist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBTNASDAQ:TWSTTwist Bioscience Corporation
02/02/202422h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TWSTTwist Bioscience Corporation
02/02/202413h30Business WireTwist Bioscience Reports Fiscal First Quarter 2024 Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
29/01/202422h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TWSTTwist Bioscience Corporation
24/01/202414h00Business WireTwist Bioscience Expands Express Genes Rapid Synthesis ServiceNASDAQ:TWSTTwist Bioscience Corporation
16/01/202414h00Business WireTwist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024NASDAQ:TWSTTwist Bioscience Corporation
10/01/202422h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/01/202414h00Business WireTwist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
05/01/202422h07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TWSTTwist Bioscience Corporation
05/01/202422h02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TWSTTwist Bioscience Corporation
05/01/202414h00Business WireTwist Bioscience Appoints Adam Laponis as Chief Financial OfficerNASDAQ:TWSTTwist Bioscience Corporation
18/12/202314h00Business WireTwist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TWSTTwist Bioscience Corporation
21/11/202322h37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TWSTTwist Bioscience Corporation
17/11/202313h45IH Market NewsFriday’s Wall Street Highlights: Applied Materials, ChargePoint, Amazon, Gap, IBM, and moreNASDAQ:TWSTTwist Bioscience Corporation
 Showing the most relevant articles for your search:NASDAQ:TWST

Dernières Valeurs Consultées

LBNK
COPIUMUSDT
COPIUM
USOTC
MEQYF
Mainstreet Equity (PK)
COIN
NSDUSD
Nasdacoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés